Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
Clinical trial NCT04270409 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04270409
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-16
- Primary completion
- 2030-10-14
- Enrollment
- 337
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.